Clinical-grade human embryonic stem cell-derived immune and matrix-regulatory cells (IMRCs) promote angiogenesis and endometrial regeneration in intrauterine adhesion (PRJCA047395)
This project investigates the therapeutic potential of clinical-grade human embryonic stem cell-derived immune and matrix-regulatory cells for the treatment of refractory moderate-to-severe intrauterine adhesion.
This project investigates the therapeutic potential of clinical-grade human embryonic stem cell-derived immune and matrix-regulatory cells for the treatment of refractory moderate-to-severe intrauterine adhesion.